Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
Researchers are conducting an observational study to assess the risk of malignancies and serious infections in people with moderate to severe systemic lupus erythematosus SLE. This study compares patients who receive the drug anifrolumab with those who receive standard care but do not start anifrolumab. The goal is to better understand safety outcomes related to these treatments in real-world settings. Participants prescribed anifrolumab according to local medical practice will be observed alongside a similar group receiving standard care. The study tracks incidents of malignancies and serious infections, including infections that result in hospitalization or death. The observation period extends up to November 2031 for malignancies and until November 2027 for infections. During the study, information about participants health will be collected from medical records over time. Researchers will monitor new cases of cancer, serious infections, and infection-related deaths. The study involves no treatment interventions beyond routine care and will last up to nearly six years, providing long-term safety data for patients with moderate to severe SLE.
Actively Recruiting
Researchers are evaluating the impact of a structured digital training program called Colo-ID on the accuracy of optical histology prediction for colorectal polyps detected during colonoscopy. The study focuses on improving the identification of polyp types using enhanced imaging, which may help optimize management strategies such as resect-and-discard for small polyps. This prospective, single-center observational study aims to assess how this training affects optical diagnosis performance in real-life clinical practice. Adults undergoing colonoscopy with at least one detected colorectal polyp will be included. During each procedure, endoscopists will record their optical prediction of the polyps histology. All polyps will be removed and sent for standard histopathological analysis. The digital training program involves a structured educational intervention to improve endoscopists skills in polyp characterization through image-based training and performance assessment. No patient management changes will occur due to the study. Participants will undergo routine colonoscopy with additional recording of optical diagnosis data before and after the training program. Researchers will compare optical prediction accuracy with histopathology results to measure concordance. Secondary assessments include diagnostic performance based on polyp size and location, inter-operator variability, and potential cost and environmental benefits. The study runs from February to June 2026 and maintains current patient care throughout.
Actively Recruiting
Researchers are studying the use of computer-aided diagnosis CAD systems during screening colonoscopy to detect colorectal lesions, including adenomas and polyps, which can sometimes be missed and may progress to advanced polyps or interval cancer. This randomized controlled trial evaluates whether CAD can reduce the risk of advanced adenomas over a 3-year period compared to standard colonoscopy. The study involves patients undergoing colonoscopy for colorectal cancer screening or due to personal or family history of colorectal cancer or polyps. Participants will be randomly assigned during their colonoscopy to receive either a standard colonoscopy or a colonoscopy enhanced with a CAD system CAD EYE or GENIUS. Following the initial procedure, patients will have a follow-up consultation about one month later to discuss histological results. At three years, a second colonoscopy using the CAD system will be performed on all patients at higher risk for colorectal cancer by a different investigator blinded to the initial results. Low-risk patients will be monitored through routine care and any colonoscopies performed outside the study. Throughout the study, participants will undergo consultations, colonoscopies, and histological assessments. Researchers will track advanced adenoma occurrence at 36 months as the primary outcome, along with secondary outcomes such as the number of adenomas, sensitivity and specificity of the CAD system, and cost comparisons. The study is designed with triple masking and randomization, with participant involvement lasting up to three years including initial and follow-up colonoscopies and consultations.
Actively Recruiting
The trial investigates the impact of different antibiotic treatments on the digestive tract colonization by extended-spectrum beta-lactamase-producing Enterobacteriaceae E-ESBL in children with febrile urinary tract infections UTIs. E-ESBL bacteria are a significant public health concern due to their resistance to many antibiotics. This research compares the emergence of E-ESBL strains in stools following treatment with either intravenous amikacin or other recommended antibiotics like ceftriaxone or cefixime in young children. Participants receive treatment for febrile UTIs with either amikacin given intravenously or with usual antibiotics such as intravenous or intramuscular ceftriaxone or oral cefixime. Before starting antibiotics, an anorectal swab is taken to check for E-ESBL colonization. A follow-up swab is performed three to four days after starting treatment to assess changes in bacterial presence. Children are monitored for the presence and type of E-ESBL bacteria in their stools four days after treatment begins. Researchers also track antibiotic resistance patterns, fever resolution, side effects related to antibiotic use, and the rate of UTI relapse over one and a half months. Participation involves stool sampling and clinical evaluations during the treatment period, with the study expected to complete by mid-2026.